StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BNGO

Bionano Genomics, Inc.

BNGO Nasdaq Laboratory Analytical Instruments EDGAR ↗
$1.12
+0.04 +4.21%

Key statistics

from XBRL data in SEC filings
Market cap
$12.8M
Revenue (TTM)
$28.7M
Net income (TTM)
-$31.6M
EPS (TTM)
$-4.46
P/E ratio
Dividend yield
Free cash flow
Cash
$3.42M
Total assets
$64.8M
Gross margin
52-week range
$1.00 – $5.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 24, 2026 8-K Director or officer change Jun 5, 2026 8-K Other events May 28, 2026 8-K Shareholder vote results May 14, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Director or officer change; Other events May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 23, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Other events Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K/A Shareholder vote results Jun 18, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement Feb 21, 2025 8-K Terminated a material agreement Feb 10, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jan 27, 2025 8-K Shareholder vote results Jan 16, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Jan 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 3, 2025 8-K Shareholder vote results Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events Oct 31, 2024 8-K Results of operations (earnings release) Oct 10, 2024 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Delisting notice or listing-rule failure Jul 18, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jul 8, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events May 28, 2024